Acorda Therapeutics, Inc. announced that John Varian has joined its board of directors, effective January 1, 2022. Mr. Varian currently serves on the board of directors for AmMax Bio and for Sellas Life Sciences, where he is Chair of the Audit Committee and on its Nominating and Goverance Committee and Science Committee.
Acorda Therapeutics, Inc. Appoints John Varian as Board of Director
January 04, 2022 at 02:31 am IST
Share
Share
© S&P Capital IQ - 2022